Fasting increases tobramycin oral absorption in mice

Antimicrob Agents Chemother. 2010 Apr;54(4):1644-6. doi: 10.1128/AAC.01172-09. Epub 2010 Jan 19.

Abstract

The pharmacokinetics of the aminoglycoside tobramycin was evaluated after oral administration to fed or fasting (15 h) mice. As expected, under normal feeding conditions, oral absorption was negligible; however, fasting induced a dramatic increase in tobramycin bioavailability. The dual-sugar test with lactulose and l-rhamnose confirmed increased small bowel permeability via the paracellular route in fasting animals. When experiments aimed at increasing the oral bioavailability of hydrophilic compounds are performed, timing of fasting should be extremely accurate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / blood
  • Anti-Bacterial Agents / pharmacokinetics*
  • Biological Availability
  • Fasting / metabolism*
  • Injections, Intramuscular
  • Injections, Intravenous
  • Intestinal Absorption
  • Lactulose / administration & dosage
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Rhamnose / administration & dosage
  • Tobramycin / administration & dosage*
  • Tobramycin / blood
  • Tobramycin / pharmacokinetics*

Substances

  • Anti-Bacterial Agents
  • Lactulose
  • Rhamnose
  • Tobramycin